Patents by Inventor Christopher Dutton

Christopher Dutton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240015847
    Abstract: A digital telephony session instantiation and control system comprises a plurality of mobile terminals in operable communication with a server executing a session controller across an IP network. Each mobile terminal is associated with a profile and the session controller is configured for matching non-disassociated user profiles and signalling to instantiate a digital telephony session between associated mobile. The session controller is configured to terminate the session upon expiry of a timer unless receiving first in-call input signals from both mobile terminals, terminates the session responsive to a second in-call input signal received from either mobile terminal and terminates the session and disassociates the profiles responsive to a third in-call input signal received from either mobile terminal.
    Type: Application
    Filed: November 18, 2021
    Publication date: January 11, 2024
    Inventor: Christopher DUTTON
  • Patent number: 4929638
    Abstract: Antiparasitic milbemycin derivatives having at the C.25 position a substituted 2-propenyl group --C(CH.sub.3).dbd.CH--R.sup.2 wherein R.sup.2 is a C.sub.3 -C.sub.8 alkyl, alkenyl or alkynyl group which may optionally contain an oxygen or sulphur atom as part of the chain, or a C.sub.3 -C.sub.8 cycloalkyl or cycloalkenyl group, or a 3 to 6 membered oxygen or sulphur containing heterocyclic ring which may optionally be substituted by one or more alkyl groups or halogen atoms; and process for their preparation.
    Type: Grant
    Filed: May 25, 1989
    Date of Patent: May 29, 1990
    Assignee: Pfizer Inc.
    Inventors: Christopher Dutton, David Perry